Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morvesept capsule/ritonavir plus entecavir vs entecavir in HBeAg-positive chronic hepatitis B
CTR20182060Phase 2Completed
- Sponsor
- Guangdong Dongyangguang Pharmaceutical
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mofesertib in Chronic Hepatitis B (CHB), sponsored by Guangdong Dongyangguang Pharmaceutical. Started Nov 2018; status: completed.
02
Drugs
mofesertib
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20182060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182060.